HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Influence of ablative margin on local tumor progression and survival in patients with HCC ≤4 cm after laser ablation.

AbstractBACKGROUND:
Ablation of the normal hepatic parenchyma surrounding the tumor (ablative margin [AM]) is necessary to prevent local tumor progression.
PURPOSE:
To assess the prognostic value of the ablative margin in patients with HCC ≤4 cm treated with US-guided laser ablation.
MATERIAL AND METHODS:
A cohort of 116 patients (53 women and 63 men, age range 42-82 years) with 132 HCC nodules ≤4 cm completely ablated by US-guided laser ablation was retrospectively analyzed. Rates of local tumor progression were compared using different ablative margin cut-offs (≥2.5, 5.0, 7.5, and 10.0 mm). Survival probability curves were obtained with the Kaplan-Meier method.
RESULTS:
The mean period of follow-up was 42 months (range 3-114 months). Local tumor progression was identified in 24 out of 132 lesions (18%), with an average time to progression of 24 months (range 6-36 months). A significant difference in local tumor progression was observed only if the ablative margin was ≥7.5 mm (7% vs. 23%, P = 0.020). Survival curves of patients with or without an ablative margin ≥7.5 mm were not different (P = 0.665; mean survival time 43.8 ± 3.1 and 46.8 ± 6.1 for an AM < or ≥7.5 mm, respectively).
CONCLUSION:
An ablative margin ≥7.5 mm turned out to be useful in preventing local tumor progression but did not affect long-term survival in patients with HCC ≤4 cm treated with laser ablation.
AuthorsGiampiero Francica, Alesssandra Petrolati, Enrico Di Stasio, Sara Pacella, Roberto Stasi, Claudio Maurizio Pacella
JournalActa radiologica (Stockholm, Sweden : 1987) (Acta Radiol) Vol. 53 Issue 4 Pg. 394-400 (May 01 2012) ISSN: 1600-0455 [Electronic] England
PMID22393158 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Hepatocellular (diagnostic imaging, surgery)
  • Chi-Square Distribution
  • Disease Progression
  • Female
  • Humans
  • Laser Therapy (methods)
  • Liver Neoplasms (diagnostic imaging, surgery)
  • Logistic Models
  • Male
  • Middle Aged
  • Probability
  • Retrospective Studies
  • Statistics, Nonparametric
  • Survival Rate
  • Treatment Outcome
  • Ultrasonography, Interventional

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: